This test is not orderable.

PredictrPK ADA Build info

Synonyms

  • PREDICTRPK ADA
  • LAB4133

Short Name

PREDICTRPK ADA

Procedure Master Number

LAB4133

Procedure ID

189665

Clinical Info

Adult Crohn’s disease: Predicts ADA levels with alternative dosing; measures ADA
clearance, serum ADA, ATA and albumin at time of sample collection.

Specimen Sources

 Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous

Specimen Types

 Blood

Container

Gold Top Tube

Collection Instructions

Container/Tube:  Gold Top Tube or red Top Tube
Specimen: 2.0 mL serum.
Collection: Anytime within the injection interval after 8 weeks of ADA therapy
Current ADA Dosing: ALL Required
  Interval ( days)    [ ] 7  [ ] 14  [ ] Other _______
  Dose (mg)    [ ] 40  [ ] 80      Date of last dose (mm/dd/yyyy) ___________

Transport Instructions

Refrigerated

Specimen Stability

7 Days Room Temperature
14 Days Refrigerated

Methodology

See report

Days Performed

TAT: 4-5 Days

Performing Laboratory

Prometheus BioScience

CPT

84999

PDM

 245306

Only Orderable at Locations:

 Orderable Everywhere

Results
Component Name Base Name Common Name External Name
SERUM ADALIMUMAB (ADA) CONCENTRATION SERADACONC SERUM ADALIMUMAB ADA CONCENTRATION Serum Adalimumab (Ada) Concentration
ANTIBODIES TO ADALIMUMAB (ATA) CONCENTRATION ATACONC ANTIBODIES TO ADALIMUMAB CONCENTRATION Antibodies To Adalimumab (Ata) Concentration
ADA ALBUMIN ADAALBUMIN ADA ALBUMIN ADA ALBUMIN
ESTIMATED ADA AT Q 7 DAYS ESTADA7DAYS ESTIMATED ADA AT Q 7 DAYS ESTIMATED ADA AT Q 7 DAYS
ESTIMATED ADA AT Q 14 DAYS ESTADA14DAYS ESTIMATED ADA AT Q 14 DAYS ESTIMATED ADA AT Q 14 DAYS
ADA CLEARANCE ADACLEARANCE ADA CLEARANCE ADA CLEARANCE
HEALTHCARE PROVIDER INPUTS HEALTHPROVIN HEALTHCARE PROVIDER INPUTS HEALTHCARE PROVIDER INPUTS
PROMETHEUS LABORATORY FOOTER PROMLABFT PROMETHEUS LABORATORY FOOTER Prometheus Laboratory Footer